Pharmacy Laws and Rules On-Demand

Pharmacy Laws and Rules On-Demand

Pharmacy Laws and Rules On-Demand

 

PHARMACY LAWS AND RULES

Florida Board of Pharmacy Laws and Rules Update                           

Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner

Upon completion of this activity, pharmacists will be able to: Review upcoming changes to 64B16.27.797 and 64B16.27.700; Discuss the rule changes that have become effective in 2023, or recently noticed and discussed during the Rules Committee meeting(s); Provide an update on e-Licensing and how to obtain electronic blue license and pharmacy permit; Examine processes associated with emergency orders enacted by the Governor. 

UAN: 0675-0000-24-010-L03-P

 

Pharmacy Legislative Update 2024                                         

Gallop P. Franklin II, PharmD., BCSCP, Assistant Professor of Pharmacy Practice, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public health,

Upon completion of this activity, pharmacists will be able to: Describe the recent changes of the 2024 Legislative Session and its effect on the profession of pharmacy; Discuss the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-24-011-L03-P

Introduction and Update on USP <797>               

Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health

Upon completion of this activity, pharmacists will be able to: Describe activities that do not fall within the scope of USP 797; Identify key differences between USP<797> of 2008 and USP<797> of 2022; Explain the differences between Category 1, Category 2, and Category 3 Pharmaceutical Compounding Sterile Preparations.

UAN: 0675-0000-24-012-L07-P

 

USP 795 and 800: Critical Regulations and Key Differences

Max Everett, Director of Quality, Olympia Compounding Pharmacy

Upon completion of this activity, pharmacists will be able to: Discuss USP <795> and <800> Regulations; Identify key differences between USP <795> and <800> and use results for program related decisions; Identify the components of a Risk Based Approach and be able to implement a Risk-Based Approach. 

UAN: 0675-0000-24-013-L07-P
 

Medication Shortages: Impact on Medication Errors and Case Reviews of Criminal Negligence

Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner

Upon completion of this activity, pharmacists will be able to: Identify root causes of current medication shortages and why the current situation is being recognized as the most severe in history; Review most recent near miss and medication errors reported which are related to/associated with medication shortages; Discuss the RaDonda Vaught vecuronium administration error in place of midazolam resulting in patient death, unintentional error, which resulted in criminal negligence in Tennessee and turned the medical world upside-down.

UAN: 0675-0000-24-014-L05-P

 

DEA Update                                                                                       

David Martin, Diversion Investigator, Drug Enforcement Administration

Upon completion of this activity, pharmacists will be able to: Discuss the purpose and structure of the Drug Enforcement Administration (DEA); Describe DEA’s roles, responsibilities, and procedures in relation to scheduled investigations/inspections; Recognize targeted areas the DEA is searching during an inspection; Discuss possible outcomes from a DEA inspection.

UAN: 0675-0000-24-015-L03-P

 

Pharmacy Inspections: Is Your Pharmacy Compliant? 

Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health

Upon completion of this activity, pharmacists will be able to: Describe the role of the Department of Health Inspectors; Outline the important steps pharmacies must complete in order to pass an inspection; Identify common problems that Department of Health inspectors experience during an inspection; Explain the responsibilities of all pharmacy staff during a routine inspection. 

UAN: 0675-0000-24-016-L03-P

 

Pharmacy Designated Person: Role and Responsibilities                    

Mark W. Mikhael PharmD, Chief Executive Officer, Olympia Compounding Pharmacy

Upon completion of this activity, pharmacists will be able to: Discuss the role and responsibilities of the Pharmacy Designated Person (PDP) in the pharmacy; Identify resources that may help with operating the pharmacy; Describe common mistakes regarding PDP’s role; List the consequences for noncompliance and how it affects the pharmacy.

UAN: 0675-0000-24-017-L03-P

No Comments

Comments are closed.